| Term 
 | Definition 
 
        | highly emetogenic, ototoxic, renal toxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Emetogenic, renal toxicity: use calvert formula for dosing |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | can be interchangeable, cause anticipatory N/V; use zofran |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | not used in lung cancer, mostly for colon |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | moderately emetogenic; dose dependent and can be neurotoxic. Does q3wk vs. weekly
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | better tolerated, careful dosing, from needles of Euu |  | 
        |  | 
        
        | Term 
 
        | Etoposide (Vespid, VD-16) |  | Definition 
 
        | mildly emetogenic, severe hypotension with rapid infusion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vinca alkyloid; neurotoxic and fatal if injected intrathecally |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vinca alkyloid; neurotoxic and fatal if injected intrathecally |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | do not inject intrathecally, other agents are administered this way. irreversible and deadly mistake especially to children |  | 
        |  | 
        
        | Term 
 
        | tyrosine kinase inhibitors |  | Definition 
 
        | cyp3A4 metabolized, many drug interactions and causes rashes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd/3rd line, improves OS by 3.3 months |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Treats NSCLC that is advance or metastasized; caused by defect in ALK gene |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits several enzymes of folate synthesis; avoid with NSAID; do not use if CrCl is less than 45 |  | 
        |  |